Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TBC1D3G Inhibitors

TBC1D3G, a member of the TBC1 domain family, is involved in cellular processes associated with vesicle trafficking and membrane dynamics. As a GTPase-activating protein (GAP), TBC1D3G plays a crucial role in regulating the activity of Rab GTPases, which are key regulators of vesicle trafficking pathways. These pathways are essential for the transport of proteins and other cargo between cellular compartments, as well as for the maintenance of membrane integrity and dynamics. Additionally, TBC1D3G has been implicated in signaling cascades related to cellular proliferation, differentiation, and survival, indicating its importance in maintaining cellular homeostasis.

Inhibition of TBC1D3G can occur through various mechanisms that disrupt its normal function and regulatory activity. One potential mechanism involves the interference with protein-protein interactions essential for TBC1D3G function. By targeting specific binding sites or domains within TBC1D3G or its interacting partners, inhibitors can disrupt the formation of functional protein complexes necessary for proper GAP activity. Another strategy for inhibition may involve the modulation of upstream signaling pathways that regulate TBC1D3G activity. By targeting components of these signaling cascades, such as kinases or transcription factors, inhibitors can disrupt the regulatory mechanisms that control TBC1D3G expression or post-translational modifications, thereby inhibiting its function. Additionally, compounds that directly bind to TBC1D3G and block its enzymatic activity may serve as potent inhibitors, preventing the GAP-mediated inactivation of Rab GTPases and disrupting vesicle trafficking pathways. Overall, elucidating the mechanisms of TBC1D3G inhibition provides insights into potential strategies for targeting this protein in various cellular contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A potent inhibitor of phosphoinositide 3-kinases (PI3K), which may indirectly affect TBC1D3G-related signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A chemical inhibitor of PI3K, which could influence TBC1D3G function indirectly by altering PI3K-dependent signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, which could influence downstream effects of TBC1D3G through mTOR signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

This compound inhibits p38 MAPK and could alter cellular processes involving TBC1D3G by affecting the MAPK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK), potentially affecting TBC1D3G's role by modulating JNK signaling.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor, which might indirectly affect TBC1D3G's function by influencing the RhoA/ROCK pathway.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Selective inhibitor of Src family kinases, potentially impacting TBC1D3G signaling indirectly.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

An Aurora kinase inhibitor, which could indirectly affect TBC1D3G's role in cellular division and signaling.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

A substance that disrupts Golgi apparatus function and could indirectly impact TBC1D3G's involvement in protein trafficking.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

A Src kinase inhibitor, which may have indirect effects on TBC1D3G by altering Src family kinase activity.